Inclusion of trans women in pre-exposure prophylaxis trials: a review
- 28 November 2014
- journal article
- review article
- Published by Taylor & Francis in AIDS Care
- Vol. 27 (5) , 637-641
Abstract
Trans women are at high risk of HIV infection. We conducted a review to determine the extent to which trans women were eligible for inclusion in and enrolled into pre-exposure prophylaxis (PrEP) efficacy trials. Out of seven trials analyzing PrEP efficacy, we found that trans women comprised only 1.2% of one trial and 0.2% of total trial enrollments. Although an additional PrEP trial to determine efficacy among trans women may not be warranted, further research is needed to determine the effectiveness of PrEP in this marginalized population, through observational and feasibility studies. These studies should focus on unique barriers that trans women may experience while obtaining access to PrEP, such as gender discrimination, transphobia, and violence.Keywords
Funding Information
- National Institute on Drug Abuse (F31-DA037808)
This publication has 29 references indexed in Scilit:
- Long-Chain Peer Referral to Recruit Black MSM and Black Transgender Women for an HIV Vaccine Efficacy TrialJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- An Overview of Depression among Transgender WomenDepression Research and Treatment, 2014
- Neighborhood-level LGBT hate crimes and current illicit drug use among sexual minority youthDrug and Alcohol Dependence, 2014
- No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure ProphylaxisPLOS ONE, 2013
- Preexposure Prophylaxis for HIV PreventionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- The Potential Impact of Pre-Exposure Prophylaxis for HIV Prevention among Men Who Have Sex with Men and Transwomen in Lima, Peru: A Mathematical Modelling StudyPLOS Medicine, 2012
- Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.2012
- Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in BotswanaNew England Journal of Medicine, 2012
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and WomenNew England Journal of Medicine, 2012
- Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.2011